SBC Medical Group Joins Russell 3000 Index and Appoints New CMO Amid Global Expansion

SBC Medical Group Holdings Inc. (NASDAQ: SBC), a leading global franchise and provider of services for aesthetic clinics, has achieved a significant milestone by being added to the Russell 3000® Index, effective as of the close of trading on June 30. This inclusion not only enhances the company's visibility among a broader base of investors but also serves as a testament to its growing relevance in the global economy. The Russell 3000 Index, a benchmark for investment managers and institutional investors, represents about $18.1 trillion in assets globally, with $10.6 trillion in the U.S. alone as of June 2024.

The addition to the Russell indexes is expected to reduce stock volatility for SBC Medical Group, as more institutional investors are likely to buy and hold the stock. This development comes at a time when the cosmetic surgery market is experiencing significant growth, particularly in Japan, where SBC Medical Group operates 251 clinics. The company reported a 5% year-over-year increase in earnings per share to $0.21 and a rise in EBITDA margins from 46% to 52% for the first quarter of 2025.

In a strategic move to bolster its brand and marketing efforts, SBC Medical Group has appointed Shinya Inoue as its new Chief Marketing Officer. Inoue, with his extensive experience in brand strategy and digital marketing at companies like Pioneer Corporation, P&G Japan, and Adobe, is set to lead the company's marketing infrastructure evolution. His appointment underscores SBC Medical Group's commitment to digital innovation and global expansion.

Yoshiyuki Aikawa, CEO of SBC Medical Group, expressed confidence in Inoue's ability to elevate the company's brand value and support its global growth initiatives. Inoue's focus will be on enhancing the Shonan Beauty Clinic brand, one of Japan's largest aesthetic medical brands, and making medical aesthetics more accessible to a wider audience.

The dual announcements of SBC Medical Group's inclusion in the Russell 3000 Index and the appointment of a new CMO highlight the company's strategic positioning for future growth in the burgeoning cosmetic surgery market. With these developments, SBC Medical Group is poised to attract more investors and strengthen its market presence both in Japan and internationally.